ZNF574 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the ZNF574 protein, a member of the zinc finger protein family. Zinc finger proteins, including ZNF574, are known for their zinc finger motifs, which are structural domains that typically facilitate binding to DNA, RNA, or other proteins. ZNF574, like many zinc finger proteins, is believed to function as a transcription factor, playing a significant role in regulating gene expression. By binding to specific DNA sequences, ZNF574 likely influences the transcription of target genes that are involved in various cellular processes such as cell growth, differentiation, and response to environmental signals. Inhibitors of ZNF574 are developed to interfere with its DNA-binding activity or disrupt its interactions with other transcriptional machinery, thereby allowing researchers to study its specific functions in gene regulation and its broader impact on cellular processes.
The development of ZNF574 inhibitors involves a comprehensive approach that begins with an in-depth analysis of the protein's structure, particularly its zinc finger domains, which are crucial for its function as a DNA-binding transcription factor. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are utilized to determine the three-dimensional configuration of ZNF574. This structural insight is essential for identifying potential binding sites where inhibitors can effectively target the protein to block its activity. Computational methods, including molecular docking and virtual screening, are employed to identify small molecules that can specifically bind to these key regions with high affinity and selectivity. Once potential inhibitors are identified, they are synthesized and subjected to in vitro testing to assess their binding properties, specificity, and inhibitory potency. Through iterative cycles of chemical refinement and optimization, these inhibitors are enhanced for better effectiveness and stability. The study of ZNF574 inhibitors not only provides insights into the specific functions of this transcription factor but also contributes to a broader understanding of the molecular mechanisms that regulate gene expression, highlighting the critical roles that zinc finger proteins play in cellular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Inhibits CDK4/6 involved in cell cycle regulation, which can lead to reduced activity of ZNF575 by limiting its availability in the proliferating cells. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Inhibits cyclin-dependent kinases, possibly resulting in decreased phosphorylation of ZNF575, thereby reducing its activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Targets CDKs, potentially leading to decreased phosphorylation and subsequent activity of ZNF575. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could lead to reduced activity of ZNF575 due to inhibited phosphorylation signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially decreasing ZNF575 activity by affecting stress response signaling pathways it may be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which could lead to reduced activity of ZNF575 by affecting downstream signaling pathways related to cell growth and proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially leading to reduced activity of ZNF575 by affecting the PI3K/AKT signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, potentially leading to reduced activity of ZNF575 by affecting the MAPK/ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, potentially leading to reduced activity of ZNF575 by affecting the PI3K/AKT signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which could lead to reduced activity of ZNF575 by affecting the MAPK/ERK pathway. | ||||||